TY  - GEN
AU  - Thaker,Premal H
AU  - Yazici,Sertac
AU  - Nilsson,Monique B
AU  - Yokoi,Kenji
AU  - Tsan,Rachel Z
AU  - He,Junqin
AU  - Kim,Sun-Jin
AU  - Fidler,Isaiah J
AU  - Sood,Anil K
TI  - Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors
SN  - 1078-0432
PY  - 2005///1207
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Blood Vessels
KW  - drug effects
KW  - Blotting, Western
KW  - Cell Line
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Inbred CBA
KW  - Mice, Nude
KW  - Ovarian Neoplasms
KW  - blood supply
KW  - Paclitaxel
KW  - administration & dosage
KW  - Platelet Endothelial Cell Adhesion Molecule-1
KW  - analysis
KW  - Proliferating Cell Nuclear Antigen
KW  - Purines
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - Xenograft Model Antitumor Assays
KW  - methods
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1158/1078-0432.CCR-04-2060
ER  -